DATATRAK Presenting Technology Expertise at ACDM

CLEVELAND, Feb. 23, 2015 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical^® technologies and delivering related services for the clinical trials industry, today announced a technology leadership role at the upcoming 2015 ACDM Conference on 18 March in Brussels.

DATATRAK will present 'Technology Trends Transforming Clinical Trials' at 11:30am CET and will take questions and answers following the presentation. The presentation focuses on how mobile technology, social media, cloud computing and big data analytics have and will continue to affect clinical research.

"Technology continues to disrupt industries and clinical research is no exception. What is surprising to us is the wide acceptance of eClinical solutions that don't provide the full benefit of technology. Those solutions require time consuming and repetitive manual processes," said Laurence P. Birch, Chairman and CEO, DATATRAK. "Our unified platform leverages the power of technology to not only eliminate these manual complexities but also deliver real-time online insight to actively manage single or multiple trials. That means a safer trial, better data quality, and time and cost savings. It's time to challenge the norm in eClinical," concluded Birch. 

Join DATATRAK Thought Leaders:

• Twitter
• LinkedIn
• SlideShare
• The DATATRAK Blog

Tweet: How #technology trends are transforming #clinicaltrials at #acdm15 http://bit.ly/1DBMWqb

About DATATRAK International, Inc.
DATATRAK International is a worldwide technology and services company delivering unified eClinical^® solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE^® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Preclinical and Phase I - Phase IV drug and device studies in multiple languages throughout the world. DATATRAK is located in Cleveland, Ohio; Bryan, Texas; Cary (RTP), North Carolina, Chicago, Illinois; and London, England. For more information, visit http://www.datatrak.com.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements
are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on November 13, 2014 announcing its results for the third quarter 2014. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/datatrak-presenting-technology-expertise-at-acdm-300039329.html

SOURCE DATATRAK International, Inc.

Copyright 2015 PR Newswire